This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The University of New Mexico, University of Kansas. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 943 
1 out of 573 
Years Active: 2015
Title: The Innovative Mind of Hadya M Khawaja: A Pioneer in Cancer Treatment
Introduction: Hadya M Khawaja, an inventive force based in Albuquerque, NM, is recognized for her groundbreaking contributions to cancer treatment through her innovative patent. With one registered patent to her name, she is making significant strides in the realm of pharmaceuticals, specifically targeting cancer-associated diseases.
Latest Patents: Khawaja's sole patent, titled "Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment," focuses on pyrazolo[1,5-a]pyrimidine compounds. These compounds are designed to inhibit cancer-associated transporter proteins, which play a critical role in drug resistance in various cancers. The invention outlines methods for treating or preventing diseases linked to these transporter proteins by administering selective efflux inhibitors that favorably target ABCG2 over ABCB1. This innovative approach aims to effectively combat drug-resistant and multiple-drug-resistant cancers, offering new hope for patients struggling with these challenging conditions.
Career Highlights: Throughout her career, Hadya M Khawaja has worked with reputable institutions, including the University of New Mexico (STC.UNM) and the University of Kansas. Her experience in these environments has allowed her to advance her research in pharmaceutical development and contribute to the scientific community significantly.
Collaborations: During her professional journey, Khawaja has collaborated with esteemed colleagues, including Richard Smith Larson and Larry A Sklar. These collaborations have enriched her research endeavors and furthered the development of her innovative cancer treatment strategies.
Conclusion: Hadya M Khawaja stands as a notable inventor whose work in developing selective efflux inhibitors is paving the way for new treatments in oncology. Her dedication to innovation and collaboration exemplifies the spirit of scientific discovery, establishing her as a key player in the field of pharmaceutical sciences. With her continued research efforts, Khawaja is poised to make even greater contributions to the fight against cancer, potentially transforming the therapeutic landscape for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile